BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dunn KE, Finan PH, Andrew Tompkins D, Strain EC. Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients. Addict Behav 2018;76:8-14. [PMID: 28735039 DOI: 10.1016/j.addbeh.2017.07.016] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Wilson M, Fritz R, Finlay M, Cook DJ. Piloting Smart Home Sensors to Detect Overnight Respiratory and Withdrawal Symptoms in Adults Prescribed Opioids. Pain Manag Nurs 2022:S1524-9042(22)00164-3. [PMID: 36175277 DOI: 10.1016/j.pmn.2022.08.011] [Reference Citation Analysis]
2 Shan X, Cao C, Yang B. Analytical Approaches for the Determination of Buprenorphine, Methadone and Their Metabolites in Biological Matrices. Molecules 2022;27:5211. [DOI: 10.3390/molecules27165211] [Reference Citation Analysis]
3 Bahadori Z, Safaie N, Mirmohammadkhani M. Comparison of psychiatric disorders in addicted patients treated with buprenorphine, methadone, and opium tincture in Iran. Middle East Curr Psychiatry 2022;29:60. [DOI: 10.1186/s43045-022-00224-x] [Reference Citation Analysis]
4 Berro LF, Zamarripa CA, Talley JT, Freeman KB, Rowlett JK. Effects of methadone, buprenorphine, and naltrexone on actigraphy-based sleep-like parameters in male rhesus monkeys. Addict Behav 2022;135:107433. [PMID: 35901553 DOI: 10.1016/j.addbeh.2022.107433] [Reference Citation Analysis]
5 Hatoum AS, Winiger EA, Morrison CL, Johnson EC, Agrawal A. Characterisation of the genetic relationship between the domains of sleep and circadian‐related behaviours with substance use phenotypes. Addiction Biology 2022;27. [DOI: 10.1111/adb.13184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Pemathilaka RL, Alimoradi N, Reynolds DE, Hashemi NN. Transport of Maternally Administered Pharmaceutical Agents Across the Placental Barrier In Vitro. ACS Appl Bio Mater 2022. [PMID: 35380796 DOI: 10.1021/acsabm.2c00121] [Reference Citation Analysis]
7 Basu A, Anand N, Das M. Sleep and Substance-Use Disorder. Sleep and Neuropsychiatric Disorders 2022. [DOI: 10.1007/978-981-16-0123-1_21] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Huffman M, Cloeren M, Ware OD, Frey JJ, Greenblatt AD, Mosby A, Oliver M, Imboden R, Bazell A, Clement J, Diaz-abad M. Poor Sleep Quality and Other Risk Factors for Unemployment Among Patients on Opioid Agonist Treatment. Subst�Abuse 2022;16:117822182210984. [DOI: 10.1177/11782218221098418] [Reference Citation Analysis]
9 Hatoum AS, Winiger EA, Morrison CL, Johnson EC, Agrawal A. Characterization of the genetic relationship between the domains of sleep and circadian-related behaviors with substance use phenotypes.. [DOI: 10.1101/2021.12.09.21267547] [Reference Citation Analysis]
10 O'Brien CB, Locklear CE, Glovak ZT, Zebadúa Unzaga D, Baghdoyan HA, Lydic R. Opioids cause dissociated states of consciousness in C57BL/6J mice. J Neurophysiol 2021;126:1265-75. [PMID: 34469699 DOI: 10.1152/jn.00266.2021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Ponce Martinez C, Edwards KA, Roos CR, Beitel M, Eller A, Barry DT. Associations Among Sleep Disturbance, Pain Catastrophizing, and Pain Intensity for Methadone-maintained Patients With Opioid Use Disorder and Chronic Pain. Clin J Pain 2020;36:641-7. [PMID: 32482968 DOI: 10.1097/AJP.0000000000000848] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
12 Hojjat SK, Kaviyani F, Amini M, Akbari H, Golmakanie E, Norozi Khalili M. The effect of Pregabalin on sleep quality of patients treated with methadone maintenance therapy: A double-blind randomized clinical trial. Journal of Substance Use 2022;27:293-9. [DOI: 10.1080/14659891.2021.1941345] [Reference Citation Analysis]
13 Tripathi R, Dhawan A, Rao R, Mishra AK, Jain R, Sinha S. Assessment of Subjective Sleep Problems in Men With Opioid Dependence Maintained on Buprenorphine. J Addict Med 2020;14:132-8. [PMID: 30964756 DOI: 10.1097/ADM.0000000000000539] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
14 Wilkerson AK, McRae-Clark AL. A review of sleep disturbance in adults prescribed medications for opioid use disorder: potential treatment targets for a highly prevalent, chronic problem. Sleep Med 2021;84:142-53. [PMID: 34153796 DOI: 10.1016/j.sleep.2021.05.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Greenwald MK, Moses TEH, Roehrs TA. At the intersection of sleep deficiency and opioid use: mechanisms and therapeutic opportunities. Transl Res 2021;234:58-73. [PMID: 33711513 DOI: 10.1016/j.trsl.2021.03.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
16 Pujasari H, Culbert GJ, Levy JA, Steffen A, Carley DW, Kapella MC. Prevalence and Correlates of Insomnia in People Living With HIV in Indonesia: A Descriptive, Cross-sectional Study. J Assoc Nurses AIDS Care 2020;31:606-14. [PMID: 32639267 DOI: 10.1097/JNC.0000000000000192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 van Veen M, Risselada R. Middelgerelateerde en verslavingsstoornissen. Slaapstoornissen in de psychiatrie 2021. [DOI: 10.1007/978-90-368-2524-5_16] [Reference Citation Analysis]
18 Rady A, Mekky J, Moulokheya T, Elsheshai A. Polysomnographic Correlates for the Risk of Relapse in Detoxified Opiate-Misuse Patients. Neuropsychiatr Dis Treat 2020;16:3187-96. [PMID: 33376334 DOI: 10.2147/NDT.S284337] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Rosen IM, Aurora RN, Kirsch DB, Carden KA, Malhotra RK, Ramar K, Abbasi-Feinberg F, Kristo DA, Martin JL, Olson EJ, Rosen CL, Rowley JA, Shelgikar AV; American Academy of Sleep Medicine Board of Directors. Chronic Opioid Therapy and Sleep: An American Academy of Sleep Medicine Position Statement. J Clin Sleep Med 2019;15:1671-3. [PMID: 31739858 DOI: 10.5664/jcsm.8062] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 21.5] [Reference Citation Analysis]
20 Fadhel FH. Exploring the relationship of sleep quality with drug use and substance abuse among university students: a cross-cultural study. Middle East Curr Psychiatry 2020;27:65. [DOI: 10.1186/s43045-020-00072-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Baldassarri SR, Beitel M, Zinchuk A, Redeker NS, Oberleitner DE, Oberleitner LMS, Carrasco D, Madden LM, Lipkind N, Fiellin DA, Bastian LA, Chen K, Yaggi HK, Barry DT. Correlates of sleep quality and excessive daytime sleepiness in people with opioid use disorder receiving methadone treatment. Sleep Breath 2020;24:1729-37. [PMID: 32556918 DOI: 10.1007/s11325-020-02123-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
22 Chrobok AI, Krause D, Winter C, Plörer D, Martin G, Koller G, Adorjan K, Canolli M, Adam R, Wagner EM, Peles E, Paul D, Vogel T, Pogarell O. Sleeping Patterns in Patients with Opioid Use Disorder: Effects of Opioid Maintenance Treatment and Detoxification. J Psychoactive Drugs 2020;52:203-10. [PMID: 32299305 DOI: 10.1080/02791072.2020.1751900] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Reid-Varley WB, Ponce Martinez C, Khurshid KA. Sleep disorders and disrupted sleep in addiction, withdrawal and abstinence with focus on alcohol and opioids. J Neurol Sci 2020;411:116713. [PMID: 32087437 DOI: 10.1016/j.jns.2020.116713] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
24 Tripathi R, Rao R, Dhawan A, Jain R, Sinha S. Opioids and sleep – a review of literature. Sleep Medicine 2020;67:269-75. [DOI: 10.1016/j.sleep.2019.06.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
25 Finan PH, Mun CJ, Epstein DH, Kowalczyk WJ, Phillips KA, Agage D, Smith MT, Preston KL. Multimodal assessment of sleep in men and women during treatment for opioid use disorder. Drug and Alcohol Dependence 2020;207:107698. [DOI: 10.1016/j.drugalcdep.2019.107698] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
26 Jake-schoffman DE, Berry MS, Donahue ML, Christou DD, Dallery J, Rung JM. Aerobic Exercise Interventions for Patients in Opioid Maintenance Treatment: A Systematic Review. Subst�Abuse 2020;14:117822182091888. [DOI: 10.1177/1178221820918885] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Zhong BL, Xu YM, Xie WX, Lu J. Frequent nightmares in Chinese patients undergoing methadone maintenance therapy: prevalence, correlates, and their association with functional impairment. Neuropsychiatr Dis Treat 2019;15:2063-72. [PMID: 31410010 DOI: 10.2147/NDT.S202813] [Reference Citation Analysis]
28 Bertz JW, Epstein DH, Reamer D, Kowalczyk WJ, Phillips KA, Kennedy AP, Jobes ML, Ward G, Plitnick BA, Figueiro MG, Rea MS, Preston KL. Sleep reductions associated with illicit opioid use and clinic-hour changes during opioid agonist treatment for opioid dependence: Measurement by electronic diary and actigraphy. J Subst Abuse Treat 2019;106:43-57. [PMID: 31540611 DOI: 10.1016/j.jsat.2019.08.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
29 Dunn KE, Huhn AS, Bergeria CL, Gipson CD, Weerts EM. Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence. J Pharmacol Exp Ther 2019;371:422-52. [PMID: 31391211 DOI: 10.1124/jpet.119.258004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
30 Valentino RJ, Volkow ND. Drugs, sleep, and the addicted brain. Neuropsychopharmacology 2020;45:3-5. [PMID: 31311031 DOI: 10.1038/s41386-019-0465-x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 13.0] [Reference Citation Analysis]
31 Hallinan R, Elsayed M, Espinoza D, Veillard AS, Morley KC, Lintzeris N, Haber P. Insomnia and excessive daytime sleepiness in women and men receiving methadone and buprenorphine maintenance treatment. Subst Use Misuse 2019;54:1589-98. [PMID: 31131668 DOI: 10.1080/10826084.2018.1552298] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
32 Li DJ, Chung KS, Wu HC, Hsu CY, Yen CF. Predictors of sleep disturbance in heroin users receiving methadone maintenance therapy: a naturalistic study in Taiwan. Neuropsychiatr Dis Treat 2018;14:2853-9. [PMID: 30464470 DOI: 10.2147/NDT.S177370] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]